New partnership will use molecular glues to tackle ‘undruggable’ disease targets
Researchers at Imperial, the Francis Crick Institute and AstraZeneca will advance the discovery of new ‘molecular glues’ to treat a range of diseases.
Advanced brain imaging study hints at how DMT alters perception of reality
Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity.
Wearable tech, AI and clinical teams join to change the face of trial monitoring
A multi-disciplinary team of researchers has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
Imperial partnering with EnteroBiotix to advance microbiome medical treatments
Imperial is partnering with biotechnology company EnteroBiotix on research into the potential of therapies based on the gut bacterial community.
Sustainable way to make breast cancer drug could boost South African production
Imperial researchers have devised a cheaper, more efficient, and sustainable way to produce a breast cancer drug in South Africa.
New flexible, steerable device placed in live brains by minimally invasive robot
Imperial College London scientists have successfully placed a bioinspired steerable catheter into the brain of an animal for the first time.
1
Observing the early universe and supporting net-zero: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Imperial College infectious diseases expert warns about drug resistance dangers
Imperial academic, Professor Alison Holmes, Professor of Infectious Diseases, appeared in front of the Science and Technology Committee last week.
“If you enjoy doing it, go ahead and do it” - women engineers in #INWED Top 50
Three Imperial engineers have been lauded in the Women’s Engineering Society (WES)’s Top 50 Women in Engineering Awards for #INWED.
1
New study shows 95% of new cancer drugs are approved in the US before Europe
Over the last decade, the US FDA is faster to approve new oncology therapies compared with the European EMA; but that speed may have consequences.
